Flow Cytometry
J15 · Effective Oct 1, 2015
30 active Medicare policies list D64.89, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Nov 1, 2020
JE · Effective Dec 6, 2020
JF · Effective Dec 6, 2020
JJ · Effective Oct 25, 2020
JM · Effective Oct 25, 2020
3 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D64.89 |
|---|---|---|
| Gonadotropin-Releasing Hormone Analogs and Antagonists | Jul 14, 2023 | Covered |
| Policy | Effective | Status of D64.89 |
|---|---|---|
| Polymerase Chain Reaction Respiratory Viral Panel Testing | Not recorded | Covered |
| Policy | Effective | Status of D64.89 |
|---|---|---|
| Thyroid Testing | Apr 15, 2026 | Covered |
J5 · Effective Oct 25, 2020
J8 · Effective Oct 25, 2020
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
National · Effective Mar 5, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J5 · Effective Oct 1, 2024
National · Effective Jan 22, 2026
National · Effective Oct 1, 2024
National · Effective Oct 1, 2024
National · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective May 14, 2026